AZD4573
AZD4573 is a potent and highly selective CDK9 inhibitor (IC50 of [1].
Product Specifications
CAS Number
2057509-72-3
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD4573.html
Purity
99.98
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
ClC1=CN=C(NC([C@H]2CCC[C@@H](NC(C)=O)C2)=O)C=C1C3=C(CC(C)(C)C4)N4N=C3
Molecular Formula
C22H28ClN5O2
Molecular Weight
429.94
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Bernard Barlaam, et al. Abstract 1650: Discovery of AZD4573, a potent and selective inhibitor of CDK9 that enables transient target engagement for the treatment of hematologic malignancies. Cancer Research. July 2018. 78 (13) : Supplement.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
CDK9
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
#90096 1x 5 mg
6-SFX (6- (Fluorescein-6-carboxamido) hexanoic acid, Succinimidyl Ester (single isomer)
Sign In for Pricing
View Details 
